Emerging Biotech Hubs: Dallas and Other U.S. Cities Making Waves in Life Sciences

These three U.S. cities are quietly emerging as significant players in the biotech industry, challenging the longstanding dominance of regions like Boston, San Francisco, and New York.

While these major hubs have traditionally led the U.S. pharma and biotech sectors, other cities are now making strides to establish themselves as key players in the life sciences arena. They are actively attracting biotech companies through strategic infrastructure investments, relocation and expansion support, grants, and various incentives.

Dallas, for example, has positioned itself as a burgeoning biotech hub, bolstered by the presence of UT Southwestern. Recently selected as one of three regional hubs for the Advanced Research Projects Agency for Health, a new federal agency within HHS, Dallas is making significant strides in the biotech field. According to Dallas city council member Omar Narvaez, the region has seen $1.6 billion in life sciences venture capital funding between 2018 and 2022, with a 33% increase in the number of researchers over the past five years. Dallas's biotech credentials extend beyond its selection as a hub for the Advanced Research Projects Agency for Health. The city boasts substantial investments in venture capital, infrastructure, business development, tax incentives, and other funding streams.

LEARN MORE